Martis Capital is working with Jefferies to sell Alcanza Clinical Research, Axios Pro has learned. Clinical trial site networks have attracted private equity’s attention because they don’t have the reimbursement challenges currently plaguing other multi-site providers.
Read the full article: Martis Capital Selling Alcanza Clinical Research //
Source: https://www.axios.com/pro/health-tech-deals/2026/07/30/martis-capital-alcanza-clinical-research-jefferies